Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, is pleased to announce that Dr Catherine Llorens-Cortes has been given the Galien France award (research category), presented at the 45th edition of these prestigious international awards, which celebrate work in pharmaceutical research annually.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2014/12/QGC_PR_Prix-Galien_20141211_UK.pdf” target=”_blank” title=”Download press release” size=”small” color=”red”]
